+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Electroporation and Electrofusion Market 2020-2024 - Product Image

Global Electroporation and Electrofusion Market 2020-2024

  • ID: 5188709
  • Report
  • October 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • MORE
Global Electroporation And Electrofusion Market 2020-2024

The publisher has been monitoring the electroporation and electrofusion market and it is poised to grow by $ 105.77 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The reports on the electroporation and electrofusion market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing incidence and prevalence of cancer and increasing investments in R&D. In addition, the growing incidence and prevalence of cancer is anticipated to boost the growth of the market as well.

The electroporation and electrofusion market analysis includes product segment and geographical landscapes.

The electroporation and electrofusion market is segmented as below:

By Product
  • Consumables
  • Systems
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rising demand for biologics as one of the prime reasons driving the electroporation and electrofusion market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The electroporation and electrofusion market report covers the following areas:
  • Electroporation and electrofusion market sizing
  • Electroporation and electrofusion market forecast
  • Electroporation and electrofusion market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroporation and electrofusion market vendors that include BEX Co. Ltd., Bio-Rad Laboratories Inc., Eppendorf AG, Harvard Bioscience Inc., Ishihara Sangyo Kaisha Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Nepa Gene Co. Ltd., and Thermo Fisher Scientific Inc. Also, the electroporation and electrofusion market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Consumables - Market size and forecast 2019-2024
  • Systems - Market size and forecast 2019-2024
  • Market opportunity by Product
Market Segmentation by End-user
  • Market segments
  • Comparison by End user
  • Industrial laboratories and CROs - Market size and forecast 2019-2024
  • Academic and government research institutes - Market size and forecast 2019-2024
  • Market opportunity by End-user
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Competitive Scenario
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Ishihara Sangyo Kaisha Ltd.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Nepa Gene Co. Ltd.
  • Thermo Fisher Scientific Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Key Finding 9
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Product - Market share 2019-2024 (%)
  • Comparison by Product
  • Consumables - Market size and forecast 2019-2024 ($ million)
  • Consumables - Year-over-year growth 2019-2024 (%)
  • Systems - Market size and forecast 2019-2024 ($ million)
  • Systems - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Product
  • End user - Market share 2019-2024 (%)
  • Comparison by End user
  • Industrial laboratories and CROs - Market size and forecast 2019-2024 ($ million)
  • Industrial laboratories and CROs - Year-over-year growth 2019-2024 (%)
  • Academic and government research institutes - Market size and forecast 2019-2024 ($ million)
  • Academic and government research institutes - Year-over-year growth 2019-2024 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • BEX Co. Ltd. - Overview
  • BEX Co. Ltd. - Product and service
  • BEX Co. Ltd. - Key offerings
  • BEX Co. Ltd. - Key customers
  • BEX Co. Ltd. - Segment focus
  • Bio-Rad Laboratories Inc. - Overview
  • Bio-Rad Laboratories Inc. - Business segments
  • Bio-Rad Laboratories Inc. - Key offerings
  • Bio-Rad Laboratories Inc. - Key customers
  • Bio-Rad Laboratories Inc. - Segment focus
  • Eppendorf AG - Overview
  • Eppendorf AG - Business segments
  • Eppendorf AG - Key offerings
  • Eppendorf AG - Key customers
  • Eppendorf AG - Segment focus
  • Harvard Bioscience Inc. - Overview
  • Harvard Bioscience Inc. - Business segments
  • Harvard Bioscience Inc. - Key offerings
  • Harvard Bioscience Inc. - Key customers
  • Harvard Bioscience Inc. - Segment focus
  • Ishihara Sangyo Kaisha Ltd. - Overview
  • Ishihara Sangyo Kaisha Ltd. - Business segments
  • Ishihara Sangyo Kaisha Ltd. - Key offerings
  • Ishihara Sangyo Kaisha Ltd. - Key customers
  • Ishihara Sangyo Kaisha Ltd. - Segment focus
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Key customers
  • Lonza Group Ltd. - Segment focus
  • MaxCyte Inc. - Overview
  • MaxCyte Inc. - Business segments
  • MaxCyte Inc. - Key offerings
  • MaxCyte Inc. - Key customers
  • MaxCyte Inc. - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • Nepa Gene Co. Ltd. - Overview
  • Nepa Gene Co. Ltd. - Product and service
  • Nepa Gene Co. Ltd. - Key offerings
  • Nepa Gene Co. Ltd. - Key customers
  • Nepa Gene Co. Ltd. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global electroporation and electrofusion market: BEX Co. Ltd., Bio-Rad Laboratories Inc., Eppendorf AG, Harvard Bioscience Inc., Ishihara Sangyo Kaisha Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Nepa Gene Co. Ltd., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the rising demand for biologics.'

According to the report, one of the major drivers for this market is the growing incidence and prevalence of cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Ishihara Sangyo Kaisha Ltd.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Nepa Gene Co. Ltd.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll